Correlation Between Elevation Oncology and AVROBIO

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Elevation Oncology and AVROBIO at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elevation Oncology and AVROBIO into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Elevation Oncology and AVROBIO, you can compare the effects of market volatilities on Elevation Oncology and AVROBIO and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elevation Oncology with a short position of AVROBIO. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elevation Oncology and AVROBIO.

Diversification Opportunities for Elevation Oncology and AVROBIO

-0.06
  Correlation Coefficient

Good diversification

The 3 months correlation between Elevation and AVROBIO is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Elevation Oncology and AVROBIO in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AVROBIO and Elevation Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elevation Oncology are associated (or correlated) with AVROBIO. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AVROBIO has no effect on the direction of Elevation Oncology i.e., Elevation Oncology and AVROBIO go up and down completely randomly.

Pair Corralation between Elevation Oncology and AVROBIO

Given the investment horizon of 90 days Elevation Oncology is expected to under-perform the AVROBIO. In addition to that, Elevation Oncology is 3.53 times more volatile than AVROBIO. It trades about -0.15 of its total potential returns per unit of risk. AVROBIO is currently generating about -0.14 per unit of volatility. If you would invest  148.00  in AVROBIO on August 26, 2024 and sell it today you would lose (8.00) from holding AVROBIO or give up 5.41% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy14.17%
ValuesDaily Returns

Elevation Oncology  vs.  AVROBIO

 Performance 
       Timeline  
Elevation Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Elevation Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
AVROBIO 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AVROBIO has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, AVROBIO is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Elevation Oncology and AVROBIO Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Elevation Oncology and AVROBIO

The main advantage of trading using opposite Elevation Oncology and AVROBIO positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elevation Oncology position performs unexpectedly, AVROBIO can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AVROBIO will offset losses from the drop in AVROBIO's long position.
The idea behind Elevation Oncology and AVROBIO pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities